DNA X Inc
SONM
9 hedge funds and large institutions have $454K invested in DNA X Inc in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
18% more capital invested
Capital invested by funds: $384K → $454K (+$69.7K)
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.46% less ownership
Funds ownership: 6.4% → 5.94% (-0.46%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWM
C2C Wealth Management
Scottsdale,
Arizona
|
+$68.8K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$56.5K |
| 3 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$4.48K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$150K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$9.84K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$84 |
| 4 |
DB
Danske Bank
Copenhagen K,
Denmark
|
-$16 |
SONM Hedge Fund Activity: Q2 2026 in Review
9 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q2 2026, worth a combined $454K — up 18% from $384K a quarter earlier.
Fund positioning in SONM was balanced in Q2 2026: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 3 trimmed.
The largest buyer was C2C Wealth Management, adding an estimated $68.8K. The largest seller was UBS Group, cutting an estimated $150K.
- 9 institutional investors held DNA X Inc (SONM) as of Q2 2026, unchanged from Q1 2026.
- Funds reported $454K of DNA X Inc stock for Q2 2026, up 18% quarter-over-quarter.
- 1 fund opened new DNA X Inc positions in Q2 2026 and 1 closed out, a net change of 0 holders.
- The largest DNA X Inc buyer in Q2 2026 was C2C Wealth Management, an estimated $68.8K added.
- The largest DNA X Inc seller in Q2 2026 was UBS Group, an estimated $150K sold.
Based on aggregated 13F filings for Q2 2026.